5248042026-05-122026-05-125248042026-05-12xbrli:pure

Prior Intimation of Board Meeting


AUROBINDO PHARMA LIMITED

General Information

NSE Symbol*AUROPHARMA
Whether Company is SME*No
ISIN*INE406A01037
Type of MeetingBoard Meeting
Details of Committee Meeting or Other Type of Meeting
Type of Intimation*New
Reason for Re-schedule (postpone or prepone) / Cancellation
Proposed Meeting Date21-05-2026
Original Meeting Date
Whether trading window is closed*Yes
Trading Window Closure- Start date01-04-2026
Details of Trading Window Closure End dateFurther to our letter dated March 23, 2026 whereby we informed the closure of Trading Window of the Company from April 1, 2026 until 48 hours from the date of declaration of the Audited Financial Results of the Company for the fourth quarter and financial year ended March 31, 2026, we inform you that the Trading Window will remain closed up to May 23, 2026 and shall be re-opened on May 24, 2026.
Date of Report12-05-2026

Agenda Details

Agenda* Financial results
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone And Consolidated
Period end TypeYearly
Period up to (Month)March
Period up to (Year)2026
Mode of raising Funds
Type of Dividend
Remarks (website dissemination)